Copyright
©The Author(s) 2015.
World J Gastroenterol. Feb 7, 2015; 21(5): 1488-1497
Published online Feb 7, 2015. doi: 10.3748/wjg.v21.i5.1488
Published online Feb 7, 2015. doi: 10.3748/wjg.v21.i5.1488
Figure 3 MiR-21 negatively regulates RAS p21 GTPase activating protein 1.
A: Luciferase reporter gene assay showed lower RLU values in pre-miR-21-LV cells co-transfected with pGL3-promoter-LucifeRASe-RASA1 in comparison with cells co-transfected with pGL3-promoter-LucifeRASe (n = 3, bP < 0.01); B: qRT-PCR detection of RASA1 mRNA levels in cells with up/down-regulated miR-21 (n = 3, aP < 0.05 vs control; cP < 0.05 vs control); C: Western blot was used to assess RASA1 protein levels in cells with up/down-regulated miR-21. 1: anti-miR-21-LV; 2: anti-NC-LV; 3: control; 4: pre-miR-21-LV; 5: pre-NC-LV. RASA1: RAS p21 GTPase activating protein 1; NC: Non-coding; LV: Lentivirus.
-
Citation: Gong B, Liu WW, Nie WJ, Li DF, Xie ZJ, Liu C, Liu YH, Mei P, Li ZJ. MiR-21/RASA1 axis affects malignancy of colon cancer cells
via RAS pathways. World J Gastroenterol 2015; 21(5): 1488-1497 - URL: https://www.wjgnet.com/1007-9327/full/v21/i5/1488.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i5.1488